Madeline King, PharmD, BCIDP

home / authors / madeline-king-pharmd-bcidp

King is an infectious diseases PGY2 residency program director, codirector of outpatient antimicrobial stewardship, and outpatient infectious diseases clinical pharmacist at Cooper University Hospital in Camden, New Jersey.

Articles

Do You Have a Minute? Asking Infectious Diseases Clinicians to Provide Uncompensated Services

Do You Have a Minute? Asking Infectious Diseases Clinicians to Provide Uncompensated Services

Madeline King, PharmD, BCIDP
November 1st 2024

ID clinicians must be paid for time spent conducting unbillable work for OPAT services.

Read More

Site Logo

Future of Fluoroquinolones: Risks, Benefits of Antibiotic Workhorse

Lucia Rose, PharmD, BCIDP;Madeline King, PharmD, BCIDP
April 8th 2019

Warnings and concerns regarding fluoroquinolones are on the rise, but the antibiotics still play a role, albeit more limited, in the treatment of various infectious diseases.

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
New Advances in Chronic Hepatitis B: Noninvasive Fibrosis Algorithm and Immunoadsorption Therapy
Published: July 1st 2025 | Updated: July 3rd 2025
New Advances in Chronic Hepatitis B: Noninvasive Fibrosis Algorithm and Immunoadsorption Therapy
West Nile Virus Dominated Arboviral Cases in 2023, as CDC Reports First US Infection With Lineage 3 Strain
Published: July 1st 2025 | Updated: July 3rd 2025
West Nile Virus Dominated Arboviral Cases in 2023, as CDC Reports First US Infection With Lineage 3 Strain
Monoclonal Antibody Shows 84% Relative Risk Reduction of Symptomatic COVID-19 vs Placebo
Published: June 29th 2025 | Updated: July 3rd 2025
Monoclonal Antibody Shows 84% Relative Risk Reduction of Symptomatic COVID-19 vs Placebo
FDA Food Recalls Announced in June 2025 Due to Potential Contamination Risks
Published: June 30th 2025 | Updated: July 3rd 2025
FDA Food Recalls Announced in June 2025 Due to Potential Contamination Risks
CDC Estimates True Valley Fever Burden May Be Up to 18 Times Higher Than Reported
Published: June 12th 2025 | Updated: July 3rd 2025
CDC Estimates True Valley Fever Burden May Be Up to 18 Times Higher Than Reported
© 2025 MJH Life Sciences

All rights reserved.